Brian Lian

President and CEO

CEO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Viking Therapeutics, Inc. (VKTX)	Chief Executive Officer	$672,000	—	$17,756,817	$2,468,016	$373,000	—	$21,269,833
2024	Viking Therapeutics, Inc. (VKTX)	Chief Executive Officer	$640,000	—	$8,468,006	$4,636,800	$440,000	$113,748	$14,298,554
2023	Viking Therapeutics, Inc. (VKTX)	Chief Executive Officer	$615,000	—	$7,937,803	$3,703,158	$372,100	—	$12,628,061
2022	Viking Therapeutics, Inc. (VKTX)	Chief Executive Officer	$611,800	—	$3,041,865	$1,404,311	$353,315	—	$5,411,291
2021	Viking Therapeutics, Inc. (VKTX)	Chief Executive Officer	$594,000	—	$1,664,600	$1,522,519	$278,000	—	$4,059,119
2020	Viking Therapeutics, Inc. (VKTX)	Chief Executive Officer	$577,000	—	$2,485,102	$1,824,346	$301,000	—	$5,187,448
2019	Viking Therapeutics, Inc. (VKTX)	Chief Executive Officer	$525,000	—	$1,530,379	$1,246,740	$210,000	—	$3,512,119
2018	Viking Therapeutics, Inc. (VKTX)	Chief Executive Officer	$485,000	—	$186,000	$465,283	$267,000	—	$1,403,283

Earnings-call appearances

Viking Therapeutics Q2 2026 Earnings Call and Webcast
Viking Therapeutics, Inc. (VKTX)

2026-07-29
Viking Therapeutics, Inc. Q1 FY2026 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2026-04-29
Viking Therapeutics, Inc. Q4 FY2025 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2026-02-11
Viking Therapeutics, Inc. Q3 FY2025 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2025-10-22
Viking Therapeutics, Inc. Q2 FY2025 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2025-07-23
Viking Therapeutics, Inc. Q4 FY2024 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2025-02-05
Viking Therapeutics, Inc. Q3 FY2024 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2024-10-23
Viking Therapeutics, Inc. Q2 FY2024 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2024-07-24
Viking Therapeutics, Inc. Q1 FY2024 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2024-04-24
Viking Therapeutics, Inc. Q4 FY2023 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2024-02-07
Viking Therapeutics, Inc. Q3 FY2023 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2023-10-25
Viking Therapeutics, Inc. Q2 FY2023 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2023-07-26
Viking Therapeutics, Inc. Q1 FY2023 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2023-04-26
Viking Therapeutics, Inc. Q4 FY2022 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2023-02-08
Viking Therapeutics, Inc. Q3 FY2022 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2022-10-26
Viking Therapeutics, Inc. Q2 FY2022 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2022-07-27
Viking Therapeutics, Inc. Q1 FY2022 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2022-04-27
Viking Therapeutics, Inc. Q4 FY2021 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2022-02-09
Viking Therapeutics, Inc. Q3 FY2021 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2021-11-03
Viking Therapeutics, Inc. Q2 FY2021 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2021-07-28
Viking Therapeutics, Inc. Q1 FY2021 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2021-04-28
Viking Therapeutics, Inc. Q4 FY2020 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2021-02-17
Viking Therapeutics, Inc. Q3 FY2020 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2020-10-28
Viking Therapeutics, Inc. Q2 FY2020 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2020-07-29
Viking Therapeutics, Inc. Q1 FY2020 Earnings Call
Viking Therapeutics, Inc. (VKTX)

2020-04-30